NO20031314L - Bicykliske heteroaromatiske forbindelser - Google Patents

Bicykliske heteroaromatiske forbindelser

Info

Publication number
NO20031314L
NO20031314L NO20031314A NO20031314A NO20031314L NO 20031314 L NO20031314 L NO 20031314L NO 20031314 A NO20031314 A NO 20031314A NO 20031314 A NO20031314 A NO 20031314A NO 20031314 L NO20031314 L NO 20031314L
Authority
NO
Norway
Prior art keywords
heteroaromatic compounds
bicyclic heteroaromatic
bicyclic
compounds
heteroaromatic
Prior art date
Application number
NO20031314A
Other languages
English (en)
Other versions
NO20031314D0 (no
NO328683B1 (no
Inventor
Cornelis Marius Timmers
Willem Frederik Johan Karstens
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20031314L publication Critical patent/NO20031314L/no
Publication of NO20031314D0 publication Critical patent/NO20031314D0/no
Publication of NO328683B1 publication Critical patent/NO328683B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20031314A 2000-09-22 2003-03-21 Bicykliske heteroaromatiske forbindelser, farmasoytiske preparater inneholdende slike samt anvendelse av slike for fremstilling av medikament for kontroll av fruktbarhet NO328683B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203287 2000-09-22
PCT/EP2001/010743 WO2002024703A1 (en) 2000-09-22 2001-09-17 Bicyclic heteroaromatic compounds

Publications (3)

Publication Number Publication Date
NO20031314L true NO20031314L (no) 2003-03-21
NO20031314D0 NO20031314D0 (no) 2003-03-21
NO328683B1 NO328683B1 (no) 2010-04-26

Family

ID=8172046

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031314A NO328683B1 (no) 2000-09-22 2003-03-21 Bicykliske heteroaromatiske forbindelser, farmasoytiske preparater inneholdende slike samt anvendelse av slike for fremstilling av medikament for kontroll av fruktbarhet

Country Status (31)

Country Link
US (2) US7229990B2 (no)
EP (2) EP1322651B1 (no)
JP (1) JP4977940B2 (no)
KR (1) KR100860040B1 (no)
CN (1) CN1247594C (no)
AR (1) AR030784A1 (no)
AT (1) ATE384726T1 (no)
AU (2) AU1392902A (no)
BR (1) BR0113987A (no)
CA (1) CA2422054C (no)
CY (1) CY1107308T1 (no)
CZ (1) CZ297136B6 (no)
DE (1) DE60132607T2 (no)
DK (1) DK1322651T3 (no)
EC (1) ECSP034523A (no)
ES (1) ES2299524T3 (no)
HR (1) HRP20030220B1 (no)
HU (1) HU229422B1 (no)
IL (2) IL154624A0 (no)
IS (1) IS2531B (no)
MX (1) MXPA03002478A (no)
NO (1) NO328683B1 (no)
NZ (1) NZ524444A (no)
PE (1) PE20020537A1 (no)
PL (1) PL207755B1 (no)
PT (1) PT1322651E (no)
RU (1) RU2271360C2 (no)
SK (1) SK287554B6 (no)
TW (1) TWI290143B (no)
WO (1) WO2002024703A1 (no)
ZA (1) ZA200301588B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4977940B2 (ja) * 2000-09-22 2012-07-18 エム・エス・ディー・オス・ベー・フェー 二環式ヘテロ芳香族化合物
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
BRPI0610133A2 (pt) * 2005-05-17 2010-06-01 Schering Corp heterociclos como agonistas de receptor de ácido nicotìnico para o tratamento de dislipidemia
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
WO2007136776A2 (en) * 2006-05-17 2007-11-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pyrimidine low molecular weight ligands for modulating hormone receptors
WO2009132980A1 (en) 2008-04-29 2009-11-05 F. Hoffmann-La Roche Ag Pyrimidinyl pyridone inhibitors of jnk.
JP5718233B2 (ja) 2008-10-20 2015-05-13 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 甲状腺刺激ホルモン受容体（ｔｓｈｒ）の低分子量アゴニスト
JP5965387B2 (ja) 2010-04-08 2016-08-03 アメリカ合衆国 Ｔｓｈ受容体用のインバースアゴニストおよびニュートラルアンタゴニスト
BR112014003981A2 (pt) 2011-08-23 2017-03-07 Endo Pharmaceuticals Inc compostos de pirimido-piridazinona e seu uso
CN113680386B (zh) * 2021-08-23 2023-08-11 深圳湾实验室坪山生物医药研发转化中心 氮杂环卡宾-方酰胺双功能催化剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2127736C1 (ru) * 1992-06-22 1999-03-20 Берингер Ингельгейм КГ Производные анеллированного дигидропиридина или их соли с физиологически переносимыми кислотами и средство, блокирующее неселективные катионные каналы
TW276256B (no) * 1993-08-26 1996-05-21 Takeda Pharm Industry Co Ltd
ES2135062T3 (es) * 1994-06-16 1999-10-16 Pfizer Pirazolo y pirrolopiridinas.
WO1997044041A1 (en) * 1996-05-20 1997-11-27 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound
JP4977940B2 (ja) * 2000-09-22 2012-07-18 エム・エス・ディー・オス・ベー・フェー 二環式ヘテロ芳香族化合物

Also Published As

Publication number Publication date
PL207755B1 (pl) 2011-01-31
HRP20030220A2 (en) 2003-06-30
HRP20030220B1 (en) 2011-10-31
RU2271360C2 (ru) 2006-03-10
TWI290143B (en) 2007-11-21
WO2002024703A1 (en) 2002-03-28
HUP0302648A3 (en) 2004-11-29
ATE384726T1 (de) 2008-02-15
ECSP034523A (es) 2003-04-25
CY1107308T1 (el) 2012-11-21
AU1392902A (en) 2002-04-02
EP1886999A8 (en) 2010-08-04
IS6732A (is) 2003-02-28
AU2002213929B2 (en) 2006-04-13
MXPA03002478A (es) 2004-05-05
US7229990B2 (en) 2007-06-12
PT1322651E (pt) 2008-02-28
NO20031314D0 (no) 2003-03-21
AR030784A1 (es) 2003-09-03
DK1322651T3 (da) 2008-06-02
CN1247594C (zh) 2006-03-29
PL360675A1 (en) 2004-09-20
KR20030040483A (ko) 2003-05-22
ZA200301588B (en) 2004-06-22
IS2531B (is) 2009-07-15
PE20020537A1 (es) 2002-06-20
JP2004509896A (ja) 2004-04-02
EP1322651A1 (en) 2003-07-02
SK3312003A3 (en) 2003-08-05
HU229422B1 (hu) 2013-12-30
BR0113987A (pt) 2003-08-12
CZ2003828A3 (cs) 2003-08-13
US20070197527A1 (en) 2007-08-23
CA2422054C (en) 2011-01-11
CA2422054A1 (en) 2002-03-28
NZ524444A (en) 2004-03-26
SK287554B6 (sk) 2011-01-04
EP1886999A3 (en) 2008-03-12
US7618963B2 (en) 2009-11-17
HK1054942A1 (en) 2003-12-19
NO328683B1 (no) 2010-04-26
CN1462273A (zh) 2003-12-17
EP1886999A2 (en) 2008-02-13
US20030225113A1 (en) 2003-12-04
IL154624A (en) 2009-09-01
EP1322651B1 (en) 2008-01-23
HUP0302648A2 (hu) 2003-11-28
KR100860040B1 (ko) 2008-09-25
DE60132607T2 (de) 2009-01-29
IL154624A0 (en) 2003-09-17
CZ297136B6 (cs) 2006-09-13
JP4977940B2 (ja) 2012-07-18
DE60132607D1 (de) 2008-03-13
ES2299524T3 (es) 2008-06-01

Similar Documents

Publication Publication Date Title
CY2015035I1 (el) Ενωσεις πυριμιδινης
NO20026196L (no) Kinazolinditosylatsalt-forbindelser
NO20024127L (no) Pyrimidin-forbindelser
DK1619192T3 (da) Arylkondeserede azapolycykliske forbindelser
NO20034774D0 (no) Melanokortinreseptorligander
AR027983A1 (es) Novedosos compuestos
NO20031314D0 (no) Bicykliske heteroaromatiske forbindelser
IS6657A (is) Ný efnasambönd
ATE372338T1 (de) Deshalogenverbindungen
AR028220A1 (es) Novedosos compuestos
NO20030303D0 (no) Kalsilytiske forbindelser
NO20023508L (no) Kalsilyttiske forbindelser
NO20031837L (no) Kalsilytiske forbindelser
ATE360010T1 (de) Heterocyclische retioidverbindungen
SE0003477D0 (sv) Compounds
SE0000620D0 (sv) Novel compounds
SE0003979D0 (sv) Novel Compounds
SE0004611D0 (sv) Novel Compounds
SE0002331D0 (sv) Novel compounds
SE0003437D0 (sv) Novel compounds
SE0003641D0 (sv) Novel compounds
SE0002234D0 (sv) Novel compounds
SE0003436D0 (sv) Novel compounds
SE0003203D0 (sv) Novel compounds
SE0004824D0 (sv) Novel compounds

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP & DOHME BV, NL

MM1K Lapsed by not paying the annual fees